|
BEMA Meetings and Workshops
The BEMA roundtable held its first official meeting in July 2000. Over the past seven years, the BEMA roundtable has met 22 times to address a wide variety of topics of interest to its members (see table below). Over 200 individuals representing over 100 organizations have thus far participated in BEMA meetings.
Meetings of the BEMA Roundtable, 2000-2007
Date
|
Description
|
Topic
|
Location
|
February 2, 2000
|
Preliminary Planning Workshop
|
R&D of Biomaterials for Biomedical Applications and Devices
Transition of Laboratory Developments to Clinical Applications
|
Washington, DC
|
July 20–21, 2000
|
1st BEMA Meeting
|
Appropriate Determination of Biocompatibility
Improving the Scientific Basis for Regulatory and Decision Making
Supply and Access of Biomaterials
|
Washington, DC
|
December 5–6, 2000
|
2nd BEMA Meeting
|
Advanced Biometallic Materials Innovation
Biomedical Device Innovation and
Risk
|
Washington, DC
|
June 11, 2001
|
3rd BEMA Meeting
|
Influence of Materials Access and Testing on Device Innovation
|
Washington, DC
|
February 7–8, 2002
|
4th BEMA Meeting: Workshop on Biomaterials Availability
|
Biomaterials Access Assurance Act
Forging Relationships
Barriers to Availability
|
Washington, DC
|
July 22–23, 2002
|
5th BEMA Meeting
|
Science-Based Testing
Implant Retrieval
Materials, Medicine, Devices, and Bioterrorism
|
Woods Hole, MA
|
December 19–20, 2002
|
6th BEMA Meeting
|
Reimbursement Policies and
Practices
|
Washington, DC
|
February 11, 2003
|
7th BEMA Meeting
|
Science-Based Assessment
Workshop Planning
|
Washington, DC
|
April 22–23, 2003
|
8th BEMA Meeting: Workshop on
Science-Based Assessment
|
Accelerating Product Development of Combination Medical Devices
Experimental Design
Bone Morphogenetic Proteins
Drug-Eluting Stents
Cell-Matrix Cartilage Implants
|
Washington, DC
|
July 14–15, 2003
|
9th BEMA Meeting
|
Perspectives on the Value of Medical Devices and Biomaterials
|
Woods Hole, MA
|
Oct. 28–29, 2003
|
10th BEMA Meeting
|
Improved Animal Model Development and Characterization
|
Washington, DC
|
April 8 – 9, 2004
|
11th BEMA Meeting
|
Chips & Arrays: Bio-Based Arrays, Genomics and Proteomics Technologies
|
Washington, DC
|
July 15–16, 2004
|
12th BEMA Meeting
|
Regulatory Pathway of Emerging Biomaterials Technologies
|
Woods Hole, MA
|
September 30–October 1, 2004
|
13th BEMA Meeting
Workshop on Biomedical Materials on the Edge
|
Convergence of New Biomedical Materials Technologies
Stem Cells
Biomolecular Materials Composites
Supramolecular Biomaterials Engineering and Design
|
Washington, DC
|
April 26, 2005
|
14th BEMA Meeting
|
Biomaterials Performance in Diabetic Patients
|
Washington, DC
|
July 28–29, 2005
|
15th BEMA Meeting
|
Small Diameter Vascular Grafts
|
Woods Hole, MA
|
October 6–7, 2005
|
16th BEMA Meeting
|
Long-Term Performance of Biomaterials
|
Washington, DC
|
May 31–June 1, 2006
|
17th BEMA Meeting
Workshop on Biomaterials and the Baby Boomers: Preclinical Testing for Our Lifetime
|
Biomaterials for Cardiovascular Applications
Biomaterials for Ophthalmic Applications
Biomaterials for Orthopaedic Applications
Future Policy Directions
|
Washington, DC
|
July 20–21, 2006
|
18th BEMA Meeting
|
Artificially Conducting the Symphony of Neurons
|
Woods Hole, MA
|
November 3, 2006
|
19th BEMA Meeting
|
Biosensors – A Discussion
|
Washington, DC
|
May 16–17, 2007
|
20th BEMA Meeting
|
Device-Centered Infection
|
Washington, DC
|
July 12–13, 2007
|
21st BEMA Meeting
|
Polymer Therapeutics
|
Woods Hole, MA
|
October 3, 2007
|
22nd BEMA Meeting
|
Novel Imaging Technologies
|
Washington, DC
|
|